Context.—Prostate cancer remains a significant public health problem. Recent publications
of randomized trials and the US Preventive Services Task Force recommendations have …

Purpose We assessed outcomes of men with prostate cancer enrolled in active surveillance.
Patients and Methods Since 1995, a total of 769 men diagnosed with prostate cancer have …

Active surveillance (AS) is an important management option for men with low-risk, clinically
localized prostate cancer. The clinical parameters for patient selection and definition of …

Active surveillance is a solution to the widely acknowledged problem of overdiagnosis and
overtreatment of clinically insignificant disease which accompanies early detection of …

OBJECTIVE To examine the outcome of patients diagnosed with 'low‐risk'prostate cancer
managed by active surveillance (AS). PATIENTS AND METHODS In all, 157 men with …

The currently available active surveillance criteria for low‐risk prostate cancer are limited by
a high rate of misclassification. The use of more selective criteria may reduce the rate of …

Introduction Prostate specific antigen (PSA) screening results in the detection of prostate
cancer in many men who are not destined to die from the disease. This often results in …

It is worth distinguishing between the two strategies of expectant management for prostate
cancer. Watchful waiting entails administering non‐curative androgen deprivation therapy to …

PURPOSE: Active surveillance for favorable risk prostate cancer is an approach that may
reduce the risk of overtreatment of clinically insignificant prostate cancer. In fact, some …

Active surveillance is an effective and well tolerated method to reduce the overtreatment
associated with screen-detected prostate cancer. About 50% of newly diagnosed patients …